Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michele L. R. Heffernan is active.

Publication


Featured researches published by Michele L. R. Heffernan.


Journal of Pharmacology and Experimental Therapeutics | 2013

Pharmacodynamic Effects of a d-Amino Acid Oxidase Inhibitor Indicate a Spinal Site of Action in Rat Models of Neuropathic Pain

Seth C. Hopkins; Fei-Yue Zhao; Carrie Bowen; Xin Fang; Haifeng Wei; Michele L. R. Heffernan; Kerry L. Spear; David Spanswick; Mark A. Varney; Thomas H. Large

Inhibition of d-amino acid oxidase (DAAO) activity is a potential target for the treatment of chronic pain. Here we characterized the effects of systemic administration of the DAAO inhibitor 4H-furo[3,2-b]pyrrole-5-carboxylic acid (SUN) in rat models of neuropathic and inflammatory pain. Oral administration of SUN dose dependently attenuated tactile allodynia induced by ligation of the L5 spinal nerve (SNL) and similarly reversed thermal hyperalgesia produced by chronic constriction injury. In addition, SUN was efficacious against complete Freund’s adjuvant-induced thermal hyperalgesia. In these models, maximal reversal of pain-related behaviors corresponded with maximum rates of increase in brain and plasma d-serine concentrations, indicative of full inhibition of DAAO activity. To investigate the possible site(s) of action, we recorded spontaneous nerve activity and mechanically evoked responses of central spinal cord dorsal horn neurons and compared these with spontaneous activity of peripheral dorsal root filaments in anesthetized SNL model animals. Oral SUN reduced spontaneous activity in both central and peripheral recordings at doses and pretreatment times that corresponded to reduced mechanical allodynia in behavioral experiments. After intravenous administration of SUN, the onset of action for this central effect was rapid (maximal effects within 30 minutes), but was abolished by severing afferent inputs to the dorsal horn. Overall, these results indicate that inhibition of DAAO in peripheral afferent spinal circuits reduced spontaneous neuronal activity to attenuate pain-related behaviors in rat models of neuropathic and inflammatory pain.


Pharmacology Research & Perspectives | 2013

Effects of D-amino acid oxidase inhibition on memory performance and long-term potentiation in vivo.

Seth C. Hopkins; Una Campbell; Michele L. R. Heffernan; Kerry L. Spear; Ross Jeggo; David Spanswick; Mark A. Varney; Thomas H. Large

N‐methyl‐d‐aspartate receptor (NMDAR) activation can initiate changes in synaptic strength, evident as long‐term potentiation (LTP), and is a key molecular correlate of memory formation. Inhibition of d‐amino acid oxidase (DAAO) may increase NMDAR activity by regulating d‐serine concentrations, but which neuronal and behavioral effects are influenced by DAAO inhibition remain elusive. In anesthetized rats, extracellular field excitatory postsynaptic potentials (fEPSPs) were recorded before and after a theta frequency burst stimulation (TBS) of the Schaffer collateral pathway of the CA1 region in the hippocampus. Memory performance was assessed after training with tests of contextual fear conditioning (FC, mice) and novel object recognition (NOR, rats). Oral administration of 3, 10, and 30 mg/kg 4H‐furo[3,2‐b]pyrrole‐5‐carboxylic acid (SUN) produced dose‐related and steady increases of cerebellum d‐serine in rats and mice, indicative of lasting inhibition of central DAAO. SUN administered 2 h prior to training improved contextual fear conditioning in mice and novel object recognition memory in rats when tested 24 h after training. In anesthetized rats, LTP was established proportional to the number of TBS trains. d‐cycloserine (DCS) was used to identify a submaximal level of LTP (5× TBS) that responded to NMDA receptor activation; SUN administered at 10 mg/kg 3–4 h prior to testing similarly increased in vivo LTP levels compared to vehicle control animals. Interestingly, in vivo administration of DCS also increased brain d‐serine concentrations. These results indicate that DAAO inhibition increased NMDAR‐related synaptic plasticity during phases of post training memory consolidation to improve memory performance in hippocampal‐dependent behavioral tests.


Archive | 2004

Pyrrole and pyrazole daao inhibitors

Q. Kevin Fang; Seth C. Hopkins; Michele L. R. Heffernan; Milan Chytil


Archive | 2000

Heterocyclic analgesic compounds and methods of use thereof

Gregory D. Cuny; Liming Shao; James R. Hauske; Michele L. R. Heffernan; Brian M. Aquila; Xinhe Wu; Fengjiang Wang; Thomas D. Bannister


Archive | 2004

Benzo[d]isoxazol-3-ol daao inhibitors

Q. Kevin Fang; Seth C. Hopkins; Michele L. R. Heffernan; Milan Chytil; Peter Wipf


Archive | 2010

Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof

Larry W. Hardy; Michele L. R. Heffernan; Frank Xinhe Wu; Kerry L. Spear; Lakshmi D. Saraswat


Archive | 2007

Fused heterocyclic inhibitors of D-amino acid oxidase

Michele L. R. Heffernan; James M. Dorsey; Qun Kevin Fang; Robert J. Foglesong; Seth C. Hopkins; Michael L. Jones; Steven W. Jones; Cyprian O. Ogbu; Joe B. Perales Jr.; Mustapha Soukri; Kerry L. Spear; Mark A. Varney


Archive | 2000

Heterocyclic analgesic compounds and their use

Gregory D. Cuny; Liming Shao; James R. Hauske; Michele L. R. Heffernan; Brian M. Aquila; Xinhe Wu; Fengjian Wang; Thomas D. Bannister


Archive | 2008

Inhibitors of d-amino acid oxidase

Michele L. R. Heffernan; Qun Kevin Fang; Robert J. Foglesong; Seth C. Hopkins; Cyprian O. Ogbu; Mustapha Soukri; Kerry L. Spear


Archive | 2010

Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase

Michele L. R. Heffernan; Richard Dennis; James M. Dorsey; Robert J. Foglesong; Michael L. Jones; Cyprian O. Ogbu; Mustapha Soukri; Kerry L. Spear; Michael Anthony Orsini

Collaboration


Dive into the Michele L. R. Heffernan's collaboration.

Researchain Logo
Decentralizing Knowledge